Author`s name Pravda.Ru

Sanofi-Aventis to Buy Chattem - Comments

Monday Moody's Investors Service said it placed ratings for Chattem Inc. on review for a possible upgrade, which follows the company's announcement it is being bought for $1.9 billion by French drug developer Sanofi-Aventis SA.

Show more

Dear readers! Please observe community rules and respect each other. We do not practice censorship. However, all offensive comments will be deleted, and their posters will be blocked.